Neurocrine Biosciences
NBIX
#1478
Rank
โ‚น1.276 T
Marketcap
โ‚น12,802
Share price
-4.73%
Change (1 day)
10.29%
Change (1 year)
Neurocrine Biosciences is an American biopharmaceutical company that develops treatments for neurological and endocrine-related diseases and disorders.

Neurocrine Biosciences (NBIX) - Total debt

Total debt on the balance sheet as of September 2025 : โ‚น38.70 Billion

According to Neurocrine Biosciences 's latest financial reports the company's total debt is โ‚น38.70 Billion. A companyโ€™s total debt is the sum of all current and non-current debts.

Neurocrine Biosciences - Total debt on balance sheet (from 1996 to 2025)

Total debt by year

Year Total debt Change
2024-12-31โ‚น39.04 B9.47%
2023-12-31โ‚น35.66 B63.93%
2022-12-31โ‚น21.75 B-33.63%
2021-12-31โ‚น32.77 B8.71%
2020-12-31โ‚น30.15 B-14.66%
2019-12-31โ‚น35.33 B30.08%
2018-12-31โ‚น27.16 B15.1%
2017-12-31โ‚น23.60 B
2009-12-31โ‚น0.53 B-27.71%
2008-12-31โ‚น0.74 B1169%
2007-12-31โ‚น58.31 M-97.55%
2006-12-31โ‚น2.37 B-11.13%
2005-12-31โ‚น2.67 B-6.66%
2004-12-31โ‚น2.86 B72.64%
2003-12-31โ‚น1.65 B335.93%
2002-12-31โ‚น0.38 B38.67%
2001-12-31โ‚น0.27 B51.92%
2000-12-31โ‚น0.18 B34.02%
1999-12-31โ‚น0.13 B5.65%
1998-12-31โ‚น0.12 B102.86%
1997-12-31โ‚น62.87 M9.32%
1996-12-31โ‚น57.52 M

Total debt for similar companies or competitors

Company Total debt/th> differencediff. Country
Repligen
RGEN
โ‚น62.23 B 60.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Royalty Pharma
RPRX
โ‚น808.21 B 1,988.17%๐Ÿ‡ฌ๐Ÿ‡ง UK
Palatin Technologies
PTN
โ‚น11.96 M-99.97%๐Ÿ‡บ๐Ÿ‡ธ USA
Eli Lilly
LLY
โ‚น3.840 T 9,822.18%๐Ÿ‡บ๐Ÿ‡ธ USA
AbbVie
ABBV
โ‚น6.210 T 15,946.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
โ‚น5.497 T 14,103.55%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
โ‚น56.04 B 44.80%๐Ÿ‡บ๐Ÿ‡ธ USA
Athersys
ATHX
โ‚น1.67 B-95.66%๐Ÿ‡บ๐Ÿ‡ธ USA